Oct 18, 2022 / 03:00PM GMT
Matthew Wiley - BioXcel Therapeutics, Inc. - Senior VP & Chief Commercial Officer
Okay. Good morning to everyone here in person and those listening via webcast. Welcome to the BioXcel Therapeutics Commercial Day. My name is Matt Wiley, I'm the Chief Commercial Officer here at BioXcel. And on behalf of everyone in our organization, thanks for joining.
Today, we're very excited to share our progress on the IGALMI launch and to share with you some early key performance indicators. We've also assembled a great panel for you today to share information on the evolving market dynamics, as well as the proposition for IGALMI. We hope that you find the presentation dated to be both relevant and elucidating.
As a reminder, during today's presentation, certain matters discussed may be forward-looking statements that are subject to risks and uncertainties related to future events and/or the future financial or business performance of the company. Actual results could differ materially from those anticipated in these forward-looking statements.
Today's presentation will focus on IGALMI,
BioXcel Therapeutics Inc Commercial Day Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot